The online version of this article (doi:10.1007/s00125-009-1413-9) contains supplementary material, which is available to authorised users.
Variation in fasting plasma glucose (FPG) within the normal range is a known risk factor for the development of type 2 diabetes. Several reports have shown that genetic variation in the genes for glucokinase (GCK), glucokinase regulatory protein (GCKR), islet-specific glucose 6 phosphatase catalytic subunit-related protein (G6PC2) and melatonin receptor type 1B (MTNR1B) is associated with FPG. In this study we examined whether these loci also contribute to type 2 diabetes susceptibility.
A random selection from the Dutch New Hoorn Study was used for replication of the association with FGP (2,361 non-diabetic participants). For the genetic association study we extended the study sample with 2,628 participants with type 2 diabetes. Risk allele counting was used to calculate a four-gene risk allele score for each individual.
Variants of the GCK, G6PC2 and MTNR1B genes but not GCKR were associated with FPG (all, p ≤ 0.001; GCKR, p = 0.23). Combining these four genes in a risk allele score resulted in an increase of 0.05 mmol/l (0.04–0.07) per additional risk allele (p = 2 × 10−13). Furthermore, participants with less than three or more than five risk alleles showed significantly different type 2 diabetes susceptibility compared with the most common group with four risk alleles (OR 0.77 [0.65–0.93], p = 0.005 and OR 2.05 [1.50–2.80], p = 4 × 10−6 respectively). The age at diagnosis was also significantly associated with the number of risk alleles (p = 0.009).
A combined risk allele score for single-nucleotide polymorphisms in four known FPG loci is significantly associated with FPG and HbA1c in a Dutch population-based sample of non-diabetic participants. Carriers of low or high numbers of risk alleles show significantly different risks for type 2 diabetes compared with the reference group.
The Diabetes Genetics Initiative of the Broad Institute of MIT and Harvard and Lund University and Novartis Institutes for BioMedical Research (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336 CrossRef
van ’t Riet E, Rijkelijkhuizen JM, Nijpels G, Dekker JM (2008) Limited agreement between HbA1c and glucose in the general Dutch population: The New Hoorn Study. Diabetologia 51:S164 abstract
World Health Organization: Definition, diagnosis and classification of Diabetes Mellitus, Report of a WHO Consultation, Part 1: Diagnosis and classification of Diabetes Mellitus, WHO/NCD/NCS/99.2, Geneva. 1-1-1999
Welschen L (2008) Disease management for patients with type 2 diabetes: towards patient empowerment. Int J Integr Care 8:e69 PubMed
Chen WM, Erdos MR, Jackson AU et al (2008) Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels. J Clin Invest 118:2620–2628 PubMed
- Combined effects of single-nucleotide polymorphisms in GCK, GCKR, G6PC2 and MTNR1B on fasting plasma glucose and type 2 diabetes risk
E. van ’t Riet
M. J. Groenewoud
L. M. C. Welschen
E. C. van Hove
J. A. Maassen
J. M. Dekker
L. M. ’t Hart
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II